Meeting
2015 ASCO Annual Meeting
POSNOC: Positive sentinel node—Adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy: A randomised trial looking at axillary treatment in early breast cancer (ISRCTN54765244).
Authors
Amit Goyal
Royal Derby Hospital, Derby, United Kingdom
Amit Goyal , Robert E. Coleman , David John Dodwell , Lesley Fallowfield , Valerie A. Jenkins , Bruce Mann , Malcolm W Reed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Local Therapy
Clinical Trial Registration Number
ISRCTN54765244
Citation
J Clin Oncol 33, 2015 (suppl; abstr TPS1103)
DOI
10.1200/jco.2015.33.15_suppl.tps1103
Abstract #
TPS1103
Poster Bd #
215b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
First Author: Augustin Vannier
Poster
2022 ASCO Annual Meeting
Adjuvant abemaciclib for high-risk early breast cancer (EBC): Factors increasing the rate of treatment discontinuations in monarchE.
First Author: Sara M. Tolaney
Poster
2021 ASCO Quality Care Symposium
Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
First Author: Saumya Umashankar
Poster
2021 ASCO Annual Meeting
Cost-effectiveness of the Oncotype DX Breast Recurrence Score test in postmenopausal women with node-positive early breast cancer based on the RxPONDER trial.
First Author: Vladislav Berdunov